Thursday, 5 December 2024
  
Login

Australia's most trusted
source of pharma news

Thursday, 05 December 2024
News

June PBS winners unveiled

Posted June 1 2023 AM

The first cannabis-based pharmaceutical approved in Australia has been expanded on the PBS for children and adults living with Lennox-Gastaut syndrome - one of three June listings announced yesterday.

Chiesi's Epidyolex, an oral cannabidiol, listed since May 2021 for Dravet Syndrome, has won reimbursement for the treatment of seizures associated with Lennox-Gastaut syndrome in patients aged two and over.

To see the whole article, please login

Popular

HCPs vote for best pharma
Disruption coming to Med Affairs
$56M drug hit with first generic
Not just an office, it's a destination
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2024 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home